Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
ESC 25: The VICTOR & VICTORIA Pooled Analysis
Author(s): Javed Butler Added: 10 months ago
ESC Congress 2025 - Vericiguat significantly reduced risks of CV mortality and HF hospitalisations, as well as all-cause mortality across both the VICTOR and VICTORIA Trial.Dr JavedButler (Baylor Scott & White Health, Dallas, US) joins us to discuss findings from a pooled analysis of the recent VICTOR and VICTORIA trials, with data from 11155 participants with heart failure with reduced ejection… View more

Heart Failure
Simple Risk Stratification Could Optimise Heart Failure Follow-Up and Outcomes
Added: 10 months ago Source:  Radcliffe Cardiology
A new nationwide cohort study from France suggests that a simple risk stratification tool based on administrative data could help tailor cardiologist follow-up for patients with heart failure (HF), potentially improving survival and optimising resource use. The study found that 40% of patients with HF do not have an annual cardiology consultation, regardless of their disease severity.¹The French… View more

Digital Health

Guidelines & Statements
Ganchimeg Ulziisaikhan
Research Area(s) / Expertise:

Heart Failure

 Job title: Cardiologist
Dr Ganchimeg Ulziisaikhan is a Cardiologist at the National Cardiovascular Center of the Third State Central Hospital in Mongolia and an active member of the Mongolian Society of Cardiologists. She holds a Bachelor's and Master's degree in Internal Medicine from Peking University Health Science Center (2009-2012) and received heart failure management training at The National Heart Center of… View more
Research Area(s) / Expertise: Job title: Managing Senior Physician
Prof Leistner is a Managing Senior Physician at the Clinic for Cardiology and Angiology, Charité Berlin, Campus Benjamin Franklin. View more
ESC Congress 2025 Releases its Late-Breaking Scientific Programme
Added: 11 months ago Source:  ESC Congress 2025 Scientific Programme
ESC Congress 2025 has released twenty-eight late-breaking trials and science sessions to be presented in August 2025.The congress is set to take place from the 29th August to 1st September at IFEMA - Fiera de Madrid.Access the full programme here.Late-Breaking Clinical Science: Inflammation and Immune Biomarkers in Cardiovascular Risk PredictionFriday 29th August, 08:15am – 09:45am (CEST… View more

Imaging & Diagnostics

Intervention
Author(s): Jacob E Møller , Christian Schulze , Andreas Goetzenich , et al Added: 6 months ago
Gain critical insights into how the landmark DanGer Shock RCT reshaped cardiogenic shock management, improved patient outcomes and enhanced collaborative care strategies in real-world settings.In this webinar, leading experts and trial investigators Dr Jacob Møller (Copenhagen University Hospital, Copenhagen, DK), Dr Vasileios Panoulas (Harefield Hospital, London, UK), Prof Christian Schulze … View more

Intervention

MI/ACS
Pedro Brugada
Research Area(s) / Expertise:

Atrial Arrhythmias

 Job title: CEO of Medical Centre Prof Brugada
Personal HistoryPedro Brugada Terradellas was born in Girona, Spain on August 11, 1952. Although his parents were both farmers with no connection to medicine, he, along with two of his three siblings, went on to study medicine in Barcelona and specialise in cardiology.1During his studies, he initially intended to specialise in haematology, but following the birth of his daughter at age 22, he… View more
Imaging the Heart Failure Patient: What Should Every HF Specialist Know?
Author(s): Victoria Delgado , Philippe Debonnaire Added: 1 month ago
Heart Failure Association Congress 2026 — Dr Philippe Debonnaire (AZ Sint Jan, Brugge, BE) and Professor Victoria Delgado (University Hospital Germans Trias i Pujol, Badalona, SP) discuss the expanding role of advanced cardiac imaging in heart failure diagnosis and management, and what a more personalised, multimodality approach means for clinical practice.The conversation moves beyond… View more

Heart Failure
Medical Options for Advanced HFpEF/HFmrEF Patients: Patient Cases
Author(s): Muthiah Vaduganathan , Added: 1 year ago
Part one of this programme explores two interactive case studies on advanced treatment options for HFpEF and HFmrEF from Prof Pardeep Jhund (University of Glasgow, UK) and Dr Muthiah Vaduganathan (Brigham and Women’s Hospital and Harvard Medical School, US). We encourage you to submit your answers on treatment options in the provided polls.These results will support part two of the programme, An… View more

Heart Failure
ESC 25 Hot Line Discussion: BETAMI-DANBLOCK: Beta-Blockers after MI
Author(s): Harriette Van Spall , Dan Atar , Anna Meta Dyrvig Kristensen Added: 9 months ago
ESC Congress 2025 - Long-term beta-blocker therapy after myocardial infarction reduced the primary endpoint of death from any cause or major adverse cardiovascular events.Late-breaker host Dr Harriette Van Spall (McMaster University, CA) sits down with Prof Dan Atar (Oslo University Hospital Ulleval, NO) and Dr Anna Meta Dyrvig Kristensen (Bispebjerg and Frederiksberg Hospital, DK) to discuss the… View more

MI/ACS

Heart Failure